Evidence map›Paper›PMID 39703302›Full record

ArticleCureus2024

Clinicopathologic Study of 28 Cases of Tubulocystic Renal Cell Carcinoma: Is It Time to Reclassify It as a Tubulocystic Renal Cell Tumor?

Guang-Qian Xiao, Vidyadhari Karne, Stephen Phan, Alicia Cuber, Richard Chiu, William D Wallace

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guang-Qian XiaoPathology, University of Southern California Keck School of Medicine, Los Angeles, USA.
Vidyadhari KarnePathology, University of Southern California Keck School of Medicine, Los Angeles, USA.
Stephen PhanPathology, University of Southern California Keck School of Medicine, Los Angeles, USA.
Alicia CuberPathology, University of Southern California Keck School of Medicine, Los Angeles, USA.
Richard ChiuPathology, University of Southern California Keck School of Medicine, Los Angeles, USA.
William D WallacePathology, University of Southern California Keck School of Medicine, Los Angeles, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tubulocystic renal cell carcinoma (TC-RCC) is uncommon and is defined by exclusive tubulocystic growth. Its clinicopathology is still evolving. Twenty-eight cases of so-defined TC-RCC were studied for clinicopathology as well as, in some cases, immunohistochemistry. The study showed the tumor had a male predominance; tumor size ranged from 0.1 cm to 3.5 cm; multifocality and peripheral location were common. More than 1/3

Indexed as

carcinomaclassificationend-stage kidney diseaseimmunohistochemistryrenal celltubulocystictubulocystic renal cell carcinomatumor

Identifiers

PMID39703302
PMCPMC11658166

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.